139 related articles for article (PubMed ID: 35042702)
21. Multivariate analysis of prognostic factors for differentiated thyroid carcinoma in children.
Jarzab B; Handkiewicz Junak D; Włoch J; Kalemba B; Roskosz J; Kukulska A; Puch Z
Eur J Nucl Med; 2000 Jul; 27(7):833-41. PubMed ID: 10952495
[TBL] [Abstract][Full Text] [Related]
22. Radioiodine treatment with 30 mCi after recombinant human thyrotropin stimulation in thyroid cancer: effectiveness for postsurgical remnants ablation and possible role of iodine content in L-thyroxine in the outcome of ablation.
Barbaro D; Boni G; Meucci G; Simi U; Lapi P; Orsini P; Pasquini C; Piazza F; Caciagli M; Mariani G
J Clin Endocrinol Metab; 2003 Sep; 88(9):4110-5. PubMed ID: 12970272
[TBL] [Abstract][Full Text] [Related]
23. Recombinant human TSH and ablation of post-surgical thyroid remnants in differentiated thyroid cancer: the effect of pre-treatment with furosemide and furosemide plus lithium.
Barbaro D; Grosso M; Boni G; Lapi P; Pasquini C; Orsini P; Turco A; Meucci G; Marzola MC; Berti P; Miccoli P; Mariani G; Rubello D
Eur J Nucl Med Mol Imaging; 2010 Feb; 37(2):242-9. PubMed ID: 19760415
[TBL] [Abstract][Full Text] [Related]
24. Risk factors of hepatic dysfunction in patients with Graves' hyperthyroidism and the efficacy of 131iodine treatment.
Wang R; Tan J; Zhang G; Zheng W; Li C
Medicine (Baltimore); 2017 Feb; 96(5):e6035. PubMed ID: 28151911
[TBL] [Abstract][Full Text] [Related]
25. Thyroglobulin assay during thyroxine treatment in low-risk differentiated thyroid cancer management: comparison with recombinant human thyrotropin-stimulated assay and imaging procedures.
Giovanella L; Ceriani L; Ghelfo A; Keller F; Sacchi A; Maffioli M; Spriano G
Clin Chem Lab Med; 2006; 44(5):648-52. PubMed ID: 16681439
[TBL] [Abstract][Full Text] [Related]
26. [Comparison of administration of rhTSH with withdrawal of thyroid hormone. Follow-up of patients with differentiated thyroid carcinoma].
Caresia AP; Castell Conesa J; Obiols Alfonso G; Pifarré Montaner P; Negre Busó M; García Alonso C; Galofré Mora P; Mesa Manteca J
Rev Esp Med Nucl; 2006; 25(4):236-41. PubMed ID: 16827986
[TBL] [Abstract][Full Text] [Related]
27. Thyroid function in the newborn in relation to maternal thyroid status during labour in a mild iodine deficiency endemic area in Sudan.
Eltom A; Eltom M; Idris M; Gebre-Medhin M
Clin Endocrinol (Oxf); 2001 Oct; 55(4):485-90. PubMed ID: 11678831
[TBL] [Abstract][Full Text] [Related]
28. Influence of radioactive iodine therapy on liver function in patients with differentiated thyroid cancer.
Wang S; Liang C; Zhao L; Meng Z; Zhang C; Jia Q; Tan J; Yang H; Liu X; Wang X
Nucl Med Commun; 2018 Dec; 39(12):1113-1120. PubMed ID: 30247387
[TBL] [Abstract][Full Text] [Related]
29. [Assessment of recombinant human thyrotropin application in following-up patients with well-differentiated thyroid carcinoma].
Rajkovaca Z; Kovacević P; Stanetić M; Ristić S
Vojnosanit Pregl; 2012 Nov; 69(11):941-6. PubMed ID: 23311243
[TBL] [Abstract][Full Text] [Related]
30. Factors related to clinical hypothyroid severity in thyroid cancer patients after thyroid hormone withdrawal.
Huang SC; Wu VC; Lin SY; Sheu WH; Song YM; Lin YH; Wu CC; Chang WD
Thyroid; 2009 Jan; 19(1):13-20. PubMed ID: 19072673
[TBL] [Abstract][Full Text] [Related]
31. Quality of life and effectiveness comparisons of thyroxine withdrawal, triiodothyronine withdrawal, and recombinant thyroid-stimulating hormone administration for low-dose radioiodine remnant ablation of differentiated thyroid carcinoma.
Lee J; Yun MJ; Nam KH; Chung WY; Soh EY; Park CS
Thyroid; 2010 Feb; 20(2):173-9. PubMed ID: 20151824
[TBL] [Abstract][Full Text] [Related]
32. Thyroid function and mortality in patients treated for hyperthyroidism.
Franklyn JA; Sheppard MC; Maisonneuve P
JAMA; 2005 Jul; 294(1):71-80. PubMed ID: 15998893
[TBL] [Abstract][Full Text] [Related]
33. Ten-year estimated risk of bone fracture in women with differentiated thyroid cancer under TSH-suppressive levothyroxine therapy.
Vera L; Gay S; Campomenosi C; Paolino S; Pera G; Monti E; Mortara L; Seriolo B; Giusti M
Endokrynol Pol; 2016; 67(4):350-8. PubMed ID: 27387240
[TBL] [Abstract][Full Text] [Related]
34. Using haematological indices to predict impaired liver function in DTC patients.
Zhou Y; Chai H
Hell J Nucl Med; 2024; 27(1):2-7. PubMed ID: 38629813
[TBL] [Abstract][Full Text] [Related]
35. Changes in TSH levels in athyreotic patients with differentiated thyroid cancer during levothyroxine therapy: influence on dose adjustments.
Grani G; Tumino D; Ramundo V; Ciotti L; Lomonaco C; Armillotta M; Falcone R; Lucia P; Maranghi M; Filetti S; Durante C
J Endocrinol Invest; 2019 Dec; 42(12):1485-1490. PubMed ID: 31203497
[TBL] [Abstract][Full Text] [Related]
36. Transient early increase in thyroglobulin levels post-radioiodine ablation in patients with differentiated thyroid cancer.
Stevic I; Dembinski TC; Pathak KA; Leslie WD
Clin Biochem; 2015 Jul; 48(10-11):658-61. PubMed ID: 25895485
[TBL] [Abstract][Full Text] [Related]
37. rhTSH-aided radioiodine ablation and treatment of differentiated thyroid carcinoma: a comprehensive review.
Luster M; Lippi F; Jarzab B; Perros P; Lassmann M; Reiners C; Pacini F
Endocr Relat Cancer; 2005 Mar; 12(1):49-64. PubMed ID: 15788638
[TBL] [Abstract][Full Text] [Related]
38. Levothyroxine suppression of thyroglobulin in patients with differentiated thyroid carcinoma.
Wang PW; Wang ST; Liu RT; Chien WY; Tung SC; Lu YC; Chen HY; Lee CH
J Clin Endocrinol Metab; 1999 Dec; 84(12):4549-53. PubMed ID: 10599717
[TBL] [Abstract][Full Text] [Related]
39. Thyroglobulin Changes are Highly Dependent on TSH in Low-risk DTC Patients not Treated with Radioiodine.
Matrone A; Faranda A; Latrofa F; Gambale C; Stefani Donati D; Molinaro E; Agate L; Viola D; Piaggi P; Torregrossa L; Basolo F; Elisei R
J Clin Endocrinol Metab; 2020 Aug; 105(8):. PubMed ID: 32453405
[TBL] [Abstract][Full Text] [Related]
40. Outcomes and Prognostic Factors in Radioiodine Refractory Differentiated Thyroid Carcinomas.
Wassermann J; Bernier MO; Spano JP; Lepoutre-Lussey C; Buffet C; Simon JM; Ménégaux F; Tissier F; Leban M; Leenhardt L
Oncologist; 2016 Jan; 21(1):50-8. PubMed ID: 26675742
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
